XML 67 R46.htm IDEA: XBRL DOCUMENT v3.22.2.2
Collaboration, License, and Other Agreements - Teva Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended 12 Months Ended 81 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2016
Sep. 30, 2022
Disaggregation of Revenue [Line Items]            
Development milestones $ 2,936.2 $ 3,452.8 $ 8,758.5 $ 11,120.0    
Other operating income | Teva            
Disaggregation of Revenue [Line Items]            
Cumulative catch-up adjustment to revenue, change in estimate of transaction price $ 31.9          
Teva Pharmaceuticals            
Disaggregation of Revenue [Line Items]            
Up-front payment received         $ 250.0  
Development Milestones | Teva Pharmaceuticals | Teva            
Disaggregation of Revenue [Line Items]            
Development milestones           $ 120.0